Founder-operator experience
Building healthcare manufacturing capability
Co-founded and operated initiatives focused on point-of-care medical devices, digital manufacturing, local production models, and access-oriented healthcare innovation.
Founder-Operator | Strategic Advisor | Healthcare Innovation | AI | Digital Manufacturing
Healthcare innovation strategy for institutions moving from ambition to implementation.
Dr. Cherise Dunn advises health systems, public institutions, universities, funders, and innovation partners on responsible AI adoption, resilient health manufacturing, health equity, partnership governance, and implementation readiness.
Advises
Health systems, public institutions, universities, funders, and innovation partners.
Focus
Responsible AI adoption, resilient health manufacturing, health equity, and implementation readiness.
Proof
Harvard, UCT, G20 Startup20, BRICS, IVLP, TEDx, and MIT AI Ventures.
Selected credibility and institutional platforms
Harvard · UCT · U.S. State Department IVLP · G20 Startup20 · BRICS · TEDx · MIT AI Ventures Founder-operator credibility across healthcare innovation, public health, digital manufacturing, and global health-policy platforms.




Founder Thesis
Dr. Cherise Dunn helps institutions make better decisions about what to build, how to govern it, who to partner with, and how to move health innovation beyond concept papers, pilot activity, funding commitments, and public ambition.
Her work connects responsible AI adoption, resilient health manufacturing, health equity, public health, and cross-sector implementation.
She is best suited for institutions working to turn health technologies, partnerships, and equity commitments into governed, fundable, and implementable models.
Selected proof
Selected roles, platforms, awards, and institutional work with direct relevance to healthcare innovation, AI adoption, digital manufacturing, and health equity implementation.
Founder-operator experience
Co-founded and operated initiatives focused on point-of-care medical devices, digital manufacturing, local production models, and access-oriented healthcare innovation.
Funding and technology-transfer support
Led funded and partner-supported initiatives that translated healthcare innovation and digital manufacturing capability into practical point-of-care production work.
Institutional partnerships
Built and supported partnerships involving Stanford University, Autodesk, Formlabs, and the U.S. State Department to advance digital manufacturing and healthcare implementation.
Global platform credibility
Selected for platforms including G20 Startup20, BRICS, IVLP, TEDx, and MIT AI Ventures, spanning health innovation, public leadership, AI, and emerging-market entrepreneurship.
Technical and public-health depth
Combines doctoral scientific training, Harvard public-health training, founder-operator experience, and practical venture-building across healthcare innovation and manufacturing.
For advisory, partnership, speaking, board, funder, or public-sector conversations, request an advisory conversation.
Advisory focus areas
Dr. Dunn helps senior leaders decide where to invest, how to structure partnerships, and how to move healthcare innovation into practice.
Her background combines founder experience, Harvard public-health training, digital manufacturing work, AI adoption strategy, and experience across international health, policy, and entrepreneurship platforms.
Typical outputs include advisory memos, strategic roadmaps, partnership architecture, AI use-case prioritisation, implementation-risk reviews, stakeholder briefings, and executive workshops.
Helping institutions decide where to invest, what to build, which partnerships matter, and how to move from ambition to implementation.
Supporting practical use-case selection, risk review, governance considerations, and implementation pathways for responsible AI adoption in healthcare and public-health settings.
Advising on point-of-care production, distributed manufacturing models, medical-device pathways, and supply resilience for healthcare systems.
Designing strategies that connect policy intent, operational delivery, access barriers, and community needs in underserved health settings.
Aligning public, private, university, funder, and implementation partners around clear roles, governance, delivery responsibilities, and shared outcomes.
Best-fit advisory situations
You are evaluating an AI or digital health initiative and need a practical adoption pathway.
You are exploring healthcare manufacturing, point-of-care production, or local capability-building.
You are designing a health equity, access, or public-health innovation initiative.
You need to align public, private, university, funder, or implementation partners.
You need an expert briefing, workshop, or strategic review before committing resources.
Selected implementation contexts
These are the institutional contexts where Dr. Dunn’s founder, public-health, digital manufacturing, and advisory experience is most useful.
The context: Healthcare systems need more resilient ways to design, produce, and deploy medical devices closer to the point of need.
Dr. Dunn’s relevance: Founder-operator experience across point-of-care medical devices, digital manufacturing, local production models, and access-oriented healthcare innovation.
Credibility signal: Funding, technology-transfer support, and partnerships connected to healthcare manufacturing and digital production capability.
The context: Promising health innovations often stall when governance, partners, operating models, and delivery responsibilities are unclear.
Dr. Dunn’s relevance: Advisor and founder experience across public health, innovation strategy, cross-sector partnerships, and implementation planning.
Credibility signal: International platform credibility across G20 Startup20, BRICS, IVLP, TEDx, and MIT AI Ventures.
The context: AI and advanced manufacturing tools need clear use cases, governance, equity safeguards, and implementation pathways before institutions commit resources.
Dr. Dunn’s relevance: Strategic advisory experience helping institutions assess use cases, operating models, partnership requirements, and access implications.
Credibility signal: Cross-sector credibility across public health, AI adoption, digital manufacturing, healthcare innovation, and international innovation platforms.
Audience fit
For teams making decisions about healthcare innovation, responsible AI adoption, manufacturing resilience, access strategy, and implementation readiness.
For institutions translating scientific, technical, or public-health work into partnerships, implementation models, and real-world adoption pathways.
For organisations assessing where funding, technology transfer, and partnership support can build credible implementation capacity and access-oriented health innovation.
For organisations needing governance-aware perspective on healthcare innovation, responsible AI adoption, manufacturing resilience, health equity, and cross-sector implementation.
For interviews, panels, and public conversations on healthcare innovation, AI adoption, digital manufacturing, health equity, and emerging-market innovation.
Speaking and media
Dr. Dunn is available for selected talks, panels, interviews, and moderated conversations on healthcare innovation, AI adoption, digital manufacturing, health equity, and implementation.
TEDx Cape Town
Talk on healthcare innovation, digital manufacturing, access, and regional capability-building.
Open talk
YouthX
Conversation on founder perspective, innovation leadership, and execution.
Open interview
Cape Health Tech
Feature on founder leadership in public health technology.
Open feature
Speaking topics
Why promising health innovations often stall and what institutions need to do differently to move from pilot activity to implementation.
Practical use cases, governance questions, risk, equity considerations, and implementation pathways for health-sector AI.
How point-of-care and distributed production models can support access, supply resilience, and healthcare innovation.
How to design innovation strategies that respond to access barriers, community needs, and real-world delivery constraints.
How institutions can turn funding, partnerships, and technology transfer into practical healthcare capability in underserved settings.
Lessons from building health innovation ventures across African and global platforms, with a focus on leadership, access, and implementation.
Public leadership
Selected public appearances across healthcare innovation, manufacturing, media, and international entrepreneurship platforms.
Press and recognition
Selected recognition across healthcare innovation, entrepreneurship, public leadership, digital manufacturing, and emerging-market innovation.
Press
Most Innovative Company recognition in South Africa.
View source
Award
Awarded for leadership in technology and innovation across Africa.
View source
Leadership Program
International Visitor Leadership Program for Women in Business.
View source
Global Forum
Delegate selection for the G20 Startup20 platform.
View source
Global Forum
Finalist distinction for emerging-markets innovation leadership.
View source
Talk Platform
TEDx Cape Town talk on healthcare innovation and regional capability.
View source
Program
AI, entrepreneurship, and venture-building program.
View source
Press
Public-interest press coverage.
View source
Recognition
Recognition for women’s leadership, innovation, and entrepreneurship.
Regional Platform
Regional trade and investment platform.
View source
FAQ
Brief answers for institutions, partners, and media.
Dr. Cherise Dunn is a founder-operator and strategic advisor working across healthcare innovation, responsible AI adoption, digital manufacturing, and health equity implementation. Her work focuses on helping institutions move promising health innovation from concept, pilot, or partnership intent into practical implementation models.
She advises on healthcare innovation strategy, responsible AI adoption in health, resilient health manufacturing capability, health equity and access implementation, and cross-sector partnership architecture. Her advisory work is most relevant when institutions are deciding what to build, how to govern it, who to partner with, and how to move from ambition to implementation.
Dr. Dunn combines doctoral scientific training, Harvard public-health training, founder-operator experience, digital manufacturing work, and international platform credibility. This allows her to connect technical, public-health, partnership, and implementation considerations in a way that is useful to institutions working across health innovation, access, and emerging technologies.
Yes. While Dr. Dunn’s founder-operator experience includes African health innovation and manufacturing contexts, her work is relevant to international institutions interested in responsible AI adoption, healthcare manufacturing resilience, health equity implementation, technology transfer, and partnerships that translate innovation into practical capability.
Best-fit conversations usually involve health systems, public institutions, universities, funders, innovation programmes, strategic partners, boards, media, and convening platforms working on healthcare innovation, responsible AI adoption, digital manufacturing, health equity, or implementation readiness.
Best-fit situations include evaluating AI or digital health initiatives, designing healthcare manufacturing or point-of-care production models, shaping health equity and access strategies, aligning cross-sector partnerships, or preparing an expert briefing before committing institutional resources.
Yes. Dr. Dunn is available for selected talks, panels, interviews, and moderated conversations on healthcare innovation beyond the pilot stage, responsible AI adoption in health systems, distributed manufacturing for healthcare resilience, health equity and access implementation, and emerging-market health innovation.
Institutions can request an advisory conversation through the contact form. Please include the organisation, decision context, timeline, stakeholders, and intended outcome. Relevant inquiries are reviewed directly, and if there is a clear fit, the next step is usually a short advisory conversation.
Work With Dr. Dunn
If your institution is evaluating responsible AI adoption, resilient health manufacturing, health equity implementation, partnership governance, or a cross-sector health innovation initiative, request an advisory conversation.
Best-fit conversations include institutional advisory, partnership scoping, speaking and media requests, board or advisory roles, funder conversations, and public-sector collaborations.
Best-fit inquiries
Please include your organisation, decision context, timeline, and intended outcome when reaching out.
Direct institutional contact
cherise_dunn@hsph.harvard.eduRelevant institutional inquiries are reviewed directly. If there is a clear fit, the next step is usually a short advisory conversation to understand the decision context, stakeholders, timeline, and intended outcome.
For media, speaking, and institutional review
Download CV